Wenzhou Capital
Overview
Wenzhou Capital is a Chinese private investment firm specializing in venture capital and private equity investments in emerging industries. The firm focuses on sectors such as biotechnology, pharmaceuticals, medical devices, healthcare, artificial intelligence, diagnostics, and medical information technology. Wenzhou Capital primarily invests in companies at various stages, including seed, early stage, growth, and late stage, with a geographical focus on China. The firm typically invests between $1 million and $50 million in each portfolio company. Wenzhou Capital's investment philosophy emphasizes value and long-term investment, aiming to comprehensively serve the upgrading and development of China's biopharmaceutical industry.
Investment Focus
- Qualified investors as defined by Chinese regulations
Portfolio Companies
Reach Wenzhou Capital directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Wenzhou Capital
What sectors does Wenzhou Capital invest in?
Wenzhou Capital invests in Healthcare, Artificial Intelligence, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Beijing, China. Wenzhou Capital is listed as a private investment firm in the ConnectSafely investor database.
What stage does Wenzhou Capital invest at?
Wenzhou Capital backs companies at Seed, Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Wenzhou Capital invest in?
Wenzhou Capital invests across China.
What companies has Wenzhou Capital invested in?
Wenzhou Capital's portfolio includes Mosheng Pharmaceutical.
Last updated · Source: ConnectSafely investor database
